BUTTERFLY EFFECTS, LLC
DEERFIELD BEACH, FLORIDA

Butterfly Effects, LLC is a premier provider of Applied Behavior Analysis (ABA) therapy services in the United States. Founded in 2004 in South Florida, the company was established with the mission to support children on the Autism Spectrum through specialized therapeutic interventions. Named after a concept from chaos theory, Butterfly Effects symbolizes the intricate and compound nature of developmental pathways and supports transformative change alongside families. Operating as one of the largest ABA therapy providers nationally, the organization employs over 500 team members who deliver services across multiple states and settings. The company's interdisciplinary approach includes collaboration among psychologists, behavior analysts, registered behavior technicians, and other professionals dedicated to service excellence. Butterfly Effects is deeply committed to working with parents to achieve personalized goals for their children, emphasizing a future enriched by improvement and growth. Core values guide the team members at Butterfly Effects, reinforcing principles such as honesty, integrity, teamwork, urgency in care, and organizational alignment with their foundational mission. The commitment extends beyond provision of therapy services; the company is dedicated to ensuring culturally sensitive, non-discriminatory practices that recognize and respect the dignity of each client. Notably registered under Florida business law (Filed Number: L05000072076) and incorporated on July 22, 2005, the organization's headquarters are located at 350 Fairway Drive, Suite 101, Deerfield Beach, FL. Contact can be made via phone at (888) 880-9270 or (954) 603-7885, with further information available on their official website at butterflyeffects.com. Leadership of the company is overseen by Manager Michael Moran and Kevin Silver, ensuring continuity of care and support transitions tailored to each client's needs. Since its inception, Butterfly Effects has been a part of crucial developments within the autism therapeutic community, evidenced by their merger event on December 17, 2018, and consistent engagement exemplified in their latest annual report dated January 17, 2024.